PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (I): Impact on PRRSV-1 Challenge Outcomes in Piglets

Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) remains an infectious agent with high importance in the swine industry. In this study, the influence of maternally derived antibodies (MDAs) on an experimental PRRSV-1 challenge is investigated. Piglets included in the study (<i>n<...

Full description

Bibliographic Details
Main Authors: Jorian Fiers, Dominiek Maes, Ann-Brigitte Cay, Laurent Mostin, Anna Parys, Marylène Tignon
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/12/1745
_version_ 1797379224265293824
author Jorian Fiers
Dominiek Maes
Ann-Brigitte Cay
Laurent Mostin
Anna Parys
Marylène Tignon
author_facet Jorian Fiers
Dominiek Maes
Ann-Brigitte Cay
Laurent Mostin
Anna Parys
Marylène Tignon
author_sort Jorian Fiers
collection DOAJ
description Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) remains an infectious agent with high importance in the swine industry. In this study, the influence of maternally derived antibodies (MDAs) on an experimental PRRSV-1 challenge is investigated. Piglets included in the study (<i>n</i> = 36) originated from a Belgian farrow-to-finish herd in which the sow population was routinely vaccinated with a modified live vaccine against PRRSV. Eighteen piglets were born from three PRRSV-seropositive sows (responders to vaccination) and had a clear presence of PRRSV-specific MDAs (E+ piglets). The other eighteen piglets were born from three PRRSV-seronegative sows (non-responders to vaccination) and did not have PRRSV-specific MDAs (E− piglets). In each group, twelve piglets were intranasally challenged with a high dose of the heterologous PRRSV-1 07V063 strain, the remaining piglets were mock-challenged (PBS) and served as controls. During the first days after infection, higher serum viremia and nasal shedding were observed in the challenged E− piglets compared to the challenged E+ piglets. However, at 10 days post-infection, the peak serum viremia was significantly higher in the E+ piglets in comparison to the E− piglets and serum viremia remained slightly higher in this group until the end of the study. Additionally, the two challenged groups had a different immune response to the PRRSV infection. The E− challenged piglets showed an earlier and more intense seroconversion, leading to significantly higher antibody titers at 10 dpi compared to the E+ challenged piglets. Furthermore, a trend towards both higher induction of serum IFN-γ and higher induction of IFN-γ secreting cells was observed in the E− challenged piglets. In contrast, a significantly higher induction of serum TNF-α at 7 dpi was seen in the E+ challenged piglets compared to the E− challenged piglets. The results gathered in this study suggest that PRRSV-specific MDAs induce partial protection during the early stages of infection but are not sufficient to protect against a high challenge dose. The presence of piglets lacking PRRSV-specific MDAs might pose a risk for PRRSV infection and enhanced transmission in pig farms in young piglets.
first_indexed 2024-03-08T20:18:04Z
format Article
id doaj.art-5a8b6fc1ae8c493d862da07156ad7d50
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-08T20:18:04Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-5a8b6fc1ae8c493d862da07156ad7d502023-12-22T14:46:52ZengMDPI AGVaccines2076-393X2023-11-011112174510.3390/vaccines11121745PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (I): Impact on PRRSV-1 Challenge Outcomes in PigletsJorian Fiers0Dominiek Maes1Ann-Brigitte Cay2Laurent Mostin3Anna Parys4Marylène Tignon5Unit Viral Re-Emerging, Enzootic and Bee Diseases, Department Infectious Diseases in Animals, Sciensano, Groeselenbergstraat 99, 1180 Ukkel, BelgiumUnit of Porcine Health Management, Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, BelgiumUnit Viral Re-Emerging, Enzootic and Bee Diseases, Department Infectious Diseases in Animals, Sciensano, Groeselenbergstraat 99, 1180 Ukkel, BelgiumUnit Experimental Centre, Department Infectious Diseases in Animals, Sciensano, Kerklaan 68, 1830 Machelen, BelgiumUnit Experimental Centre, Department Infectious Diseases in Animals, Sciensano, Kerklaan 68, 1830 Machelen, BelgiumUnit Viral Re-Emerging, Enzootic and Bee Diseases, Department Infectious Diseases in Animals, Sciensano, Groeselenbergstraat 99, 1180 Ukkel, BelgiumPorcine Reproductive and Respiratory Syndrome Virus (PRRSV) remains an infectious agent with high importance in the swine industry. In this study, the influence of maternally derived antibodies (MDAs) on an experimental PRRSV-1 challenge is investigated. Piglets included in the study (<i>n</i> = 36) originated from a Belgian farrow-to-finish herd in which the sow population was routinely vaccinated with a modified live vaccine against PRRSV. Eighteen piglets were born from three PRRSV-seropositive sows (responders to vaccination) and had a clear presence of PRRSV-specific MDAs (E+ piglets). The other eighteen piglets were born from three PRRSV-seronegative sows (non-responders to vaccination) and did not have PRRSV-specific MDAs (E− piglets). In each group, twelve piglets were intranasally challenged with a high dose of the heterologous PRRSV-1 07V063 strain, the remaining piglets were mock-challenged (PBS) and served as controls. During the first days after infection, higher serum viremia and nasal shedding were observed in the challenged E− piglets compared to the challenged E+ piglets. However, at 10 days post-infection, the peak serum viremia was significantly higher in the E+ piglets in comparison to the E− piglets and serum viremia remained slightly higher in this group until the end of the study. Additionally, the two challenged groups had a different immune response to the PRRSV infection. The E− challenged piglets showed an earlier and more intense seroconversion, leading to significantly higher antibody titers at 10 dpi compared to the E+ challenged piglets. Furthermore, a trend towards both higher induction of serum IFN-γ and higher induction of IFN-γ secreting cells was observed in the E− challenged piglets. In contrast, a significantly higher induction of serum TNF-α at 7 dpi was seen in the E+ challenged piglets compared to the E− challenged piglets. The results gathered in this study suggest that PRRSV-specific MDAs induce partial protection during the early stages of infection but are not sufficient to protect against a high challenge dose. The presence of piglets lacking PRRSV-specific MDAs might pose a risk for PRRSV infection and enhanced transmission in pig farms in young piglets.https://www.mdpi.com/2076-393X/11/12/1745PRRSVvaccinationviremiachallengeimmune responsematernally derived antibodies
spellingShingle Jorian Fiers
Dominiek Maes
Ann-Brigitte Cay
Laurent Mostin
Anna Parys
Marylène Tignon
PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (I): Impact on PRRSV-1 Challenge Outcomes in Piglets
Vaccines
PRRSV
vaccination
viremia
challenge
immune response
maternally derived antibodies
title PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (I): Impact on PRRSV-1 Challenge Outcomes in Piglets
title_full PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (I): Impact on PRRSV-1 Challenge Outcomes in Piglets
title_fullStr PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (I): Impact on PRRSV-1 Challenge Outcomes in Piglets
title_full_unstemmed PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (I): Impact on PRRSV-1 Challenge Outcomes in Piglets
title_short PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (I): Impact on PRRSV-1 Challenge Outcomes in Piglets
title_sort prrsv vaccinated seronegative sows and maternally derived antibodies i impact on prrsv 1 challenge outcomes in piglets
topic PRRSV
vaccination
viremia
challenge
immune response
maternally derived antibodies
url https://www.mdpi.com/2076-393X/11/12/1745
work_keys_str_mv AT jorianfiers prrsvvaccinatedseronegativesowsandmaternallyderivedantibodiesiimpactonprrsv1challengeoutcomesinpiglets
AT dominiekmaes prrsvvaccinatedseronegativesowsandmaternallyderivedantibodiesiimpactonprrsv1challengeoutcomesinpiglets
AT annbrigittecay prrsvvaccinatedseronegativesowsandmaternallyderivedantibodiesiimpactonprrsv1challengeoutcomesinpiglets
AT laurentmostin prrsvvaccinatedseronegativesowsandmaternallyderivedantibodiesiimpactonprrsv1challengeoutcomesinpiglets
AT annaparys prrsvvaccinatedseronegativesowsandmaternallyderivedantibodiesiimpactonprrsv1challengeoutcomesinpiglets
AT marylenetignon prrsvvaccinatedseronegativesowsandmaternallyderivedantibodiesiimpactonprrsv1challengeoutcomesinpiglets